Virtual Medicinal Product (VMP) - Generic COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Generic COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials Start Date 23-02-2022 End Date
Previous Name Previous Name Generic COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials Start Date 16-03-2021 End Date 22-02-2022

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
0.5
UDFS UOM
ml
Unit Dose UOM
dose

Summary

Prescribing Status
Never Valid To Prescribe As A VMP
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Dispersion for injection
Ontology Form/Route
dispersioninjection.intramuscular
Name Basis
Other

Codes

ATC Code
n/a
BNF Start Date End Date
Current BNF 14040000 Start Date 04-04-2022 End Date
Previous BNF 14040000 Start Date 16-03-2021 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39478211000001100 16-03-2021

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 dose
100 dose
500 dose